In line with this hypothesis, Kelly and coworkers have demonstrated that retroviral transduction of FLT3-ITD into bone marrow cells obtained from PML-RARA transgenic mice resulted in an APL-like disease developing with a short latency [56]. The gene discussed is RARA; the disease is acute promyelocytic leukemia.